Skip to main content
Tech.euFundingExplorerBeta

Pure Biologics

Pure Biologics specializing in research and development in the field of innovative biological medicines, diagnostic tests and medical devices with therapeutic use.

Pure Biologics has raised €9.2M across 2 funding rounds from 1 investor, most recently a round in Oct 2019. Based in Warsaw, Poland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€9.2M
€9,177,801
Funding rounds
2
Investors
1
distinct backers
Active since
2019-04
latest 2019-10

Funding by year

EUR raised per year
Pure Biologics — funding by year — interactive chart.
Data table
Pure Biologics — funding by year
2019€9.2M

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
  • ▲ 7y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2019-10-01Other€6.8MNational Center for Research and DevelopmentView deal →
2019-04-01Other€2.3M—View deal →

Similar companies

same sector or country

Global coverage: FundingData